Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neuroma, Acoustic 3Surgical Wound Infection 2Stomatitis 2Nasopharyngeal Carcinoma 2Breast Neoplasms 2Sepsis 1Neutropenia 1Neoplasms 1Nasopharyngeal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Gentamicins × Clear all
NCT07220967 2026-04-09

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

Memorial Sloan Kettering Cancer Center

Phase 4 Recruiting
392 enrolled
Breast

Breast Neoplasms

NCT02395614 2022-01-26

Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation

Vanderbilt University Medical Center

Phase NA Completed
88 enrolled 10 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡